Online registration is now closed, there will be a limited number of onsite registrations on Monday

The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, reshaping clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio for our inaugural Digital Health Impact 2019 event at the InterContinental Boston at 510 Atlantic Ave, Boston, MA 02210, part of Biotech Week Boston, as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for life sciences and digital health innovators to converge and ultimately deliver better outcomes for patients. Contact Laura Rudberg for sponsorship opportunities. View our sponsorship prospectus here

Senior Advisor to Dana Farber
Luba brings to Google pharmaceutical, biotechnology, and digital health industry experience and expertise in building and investing in innovative technology companies and providing strategic counsel to global corporations. Previously, Luba has served as Vice President of Global Business Development and Mergers & Acquisitions at Roche, where she also established and led the East Coast Innovation Hub for the Diagnostics Division. Luba is on the Board of MassBio and Brooklyn ImmunoTherapeutics, and serves as Advisor to the Dana-Farber Cancer Institute, as part of its Business Development Council. Luba is a Thought Leader for the New England Journal of Medicine (NEJM) Catalyst, Founder of the Pharma Digital Health Roundtable, and a Lecturer at Boston University Law School and School of Management where she has taught courses in life sciences, business law, innovation, and entrepreneurship since 2014. Luba’s career has spanned leadership roles in venture investing, business development, Mergers & Acquisitions, law, and operations, previously serving as Venture Partner at Colt Ventures, leading BD and Strategy for Axcella Health, a Flagship Ventures company, and serving as Senior Mergers & Acquisitions Counsel at Pfizer Inc. Luba began her career practicing law at a leading national law firm, Wilmer Cutler Pickering Hale and Dorr, where she represented clients in securities, IP, regulatory, corporate, and litigation matters. Luba is a recipient of several awards and honors for her work in the community, including the Science Club for Girls Catalyst Award for her commitment to advocating for women in science and technology. Luba served as a non-profit board member of Longwood Symphony Orchestra, executive coach for MassNextGen, co-chair of MassBio’s Entrepreneur’s University, and mentor and judge for MassCONNECT, MIT 100K Entrepreneurship Competition, and MassChallenge.

Brought to you by